{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:28:13Z","timestamp":1792740493927,"version":"4.5.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bpobgyn.2022.102301","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T02:19:50Z","timestamp":1672107590000},"page":"102301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Treatment algorithms for high responders: What we can learn from randomized controlled trials, real-world data and models"],"prefix":"10.1016","volume":"86","author":[{"given":"Panagiotis","family":"Drakopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakoub","family":"Khalaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro C.","family":"Esteves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos P.","family":"Polyzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sesh K.","family":"Sunkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Botros","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Koloda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Salle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Lispi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"D'Hooghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"La Marca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2022.102301_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/humrep\/dex334","article-title":"The number of oocytes retrieved during IVF: a balance between efficacy and safety","volume":"33","author":"Magnusson","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.fertnstert.2017.06.005","article-title":"The international glossary on infertility and fertility care, 2017","volume":"108","author":"Zegers-Hochschild","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fendo.2018.00461","article-title":"Defining low prognosis patients undergoing assisted reproductive technology: POSEIDON criteria-the why","volume":"9","author":"Esteves","year":"2018","journal-title":"Front Endocrinol"},{"issue":"9","key":"10.1016\/j.bpobgyn.2022.102301_bib4","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/humrep\/dev149","article-title":"Sub-optimal responders following controlled ovarian stimulation: an overlooked group?","volume":"30","author":"Polyzos","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib5","article-title":"ESHRE guideline: ovarian stimulation for IVF\/ICSI","volume":"2","author":"Bosch","year":"2020","journal-title":"Human Reproduction Open"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib6","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10815-010-9387-6","article-title":"Ovarian hyperstimulation syndrome: pathophysiology and prevention","volume":"27","author":"Nastri","year":"2010","journal-title":"J\u00a0Assist Reprod Genet"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib8","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.fertnstert.2013.12.026","article-title":"Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in\u00a0vitro fertilization cycles","volume":"101","author":"Steward","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice","volume":"20","author":"La Marca","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.fertnstert.2014.04.047","article-title":"Human chorionic gonadotropin vs. gonadotropin-releasing hormone agonist trigger in assisted reproductive technology--\"the king is dead, long live the king","volume":"102","author":"Humaidan","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib11","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3109\/19396368.2015.1089607","article-title":"The continuum of high ovarian response: a rational approach to the management of high responder patient subgroups","volume":"61","author":"Gat","year":"2015","journal-title":"Syst Biol Reprod Med"},{"issue":"6","key":"10.1016\/j.bpobgyn.2022.102301_bib12","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.fertnstert.2018.04.037","article-title":"Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients","volume":"109","author":"Mol","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib13","first-page":"1634","article-title":"Practice Committee of the American society for reproductive medicine","volume":"106","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib14","article-title":"Factors associated with ovarian hyperstimulation syndrome (OHSS) severity in women with polycystic ovary syndrome undergoing IVF\/ICSI","volume":"11","author":"Sun","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1472-6483(10)60127-7","article-title":"Poor ovarian response to gonadotrophin stimulation is associated with FSH receptor polymorphism","volume":"18","author":"Achrekar","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/humupd\/dmy019","article-title":"Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis","volume":"24","author":"Alviggi","year":"2018","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib17","first-page":"531","volume":"89","author":"Engmann","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib18","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00404-011-2172-7","article-title":"Ovarian reserve and in\u00a0vitro fertilization cycles outcome according to women smoking status and stimulation regimen","volume":"285","author":"Freour","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib19","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2010.07.1069","article-title":"Age-specific nomogram for the decline in antral follicle count throughout the reproductive period","volume":"95","author":"La Marca","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/FPC.0000000000000374","article-title":"The N680S variant in the follicle-stimulating hormone receptor gene identifies hyperresponders to controlled ovarian stimulation","volume":"29","author":"Nenonen","year":"2019","journal-title":"Pharmacogenetics Genom"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib21","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1093\/humrep\/deab068","article-title":"The effect of polymorphisms in FSHR and FSHB genes on ovarian response: a prospective multicenter multinational study in Europe and Asia","volume":"36","author":"Polyzos","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib22","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s10815-015-0600-5","article-title":"Effect of follicle-stimulating hormone receptor Asn680Ser polymorphism on the outcomes of controlled ovarian hyperstimulation: an updated meta-analysis of 16 cohort studies","volume":"32","author":"Tang","year":"2015","journal-title":"J\u00a0Assist Reprod Genet"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib23","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(03)14410-8","article-title":"Formation and early development of follicles in the polycystic ovary","volume":"362","author":"Webber","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib24","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1093\/humrep\/deab207","article-title":"Assessing couples' preferences for fresh or frozen embryo transfer: a discrete choice experiment","volume":"36","author":"Abdulrahim","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib25","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1080\/09513590.2019.1650345","article-title":"Decision points for individualized hormonal stimulation with recombinant gonadotropins for treatment of women with infertility","volume":"35","author":"Lunenfeld","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib26","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/humrep\/dex319","article-title":"Individualized versus standard FSH dosing in women starting IVF\/ICSI: an RCT. Part 2: the predicted hyper responder","volume":"32","author":"Oudshoorn","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib27","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/humrep\/deg472","article-title":"A\u00a0prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU\/day in 'standard' patients undergoing IVF\/ICSI treatment","volume":"18","author":"Popovic-Todorovic","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib28","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1093\/humrep\/dew149","article-title":"Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials","volume":"31","author":"Humaidan","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fendo.2019.00181","article-title":"Individualization of FSH doses in assisted reproduction: facts and fiction","volume":"10","author":"Broekmans","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149615","article-title":"Prediction of ovarian hyperstimulation syndrome in patients treated with corifollitropin alfa or rFSH in a GnRH antagonist protocol","volume":"11","author":"Griesinger","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib31","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1471-0528.2012.03412.x","article-title":"Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in\u00a0vitro fertilisation cycles","volume":"119","author":"La Marca","year":"2012","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"La Marca","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib33","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dem204","article-title":"Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy","volume":"22","author":"Nelson","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib34","first-page":"165","article-title":"Characterisation of population pharmacokinetics and endogenous follicle-stimulating hormone (FSH) levels after multiple dosing of a recombinant human FSH in HEalthy women","volume":"16","author":"Rose","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib35","first-page":"265","article-title":"How can personalized medicine improve assisted reproduction technology outcomes?","volume":"18","author":"Sadeghi","year":"2017","journal-title":"J\u00a0Reproduction Infertil"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib36","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/humrep\/dex012","article-title":"The addition of anti-Mullerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial","volume":"32","author":"Magnusson","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib37","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.2147\/DDDT.S104104","article-title":"PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome","volume":"10","author":"Yovich","year":"2016","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib38","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/humrep\/dey061","article-title":"Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth rates","volume":"33","author":"La Marca","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12958-021-00744-x","article-title":"Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007\u20132017)","volume":"19","author":"Fatemi","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib40","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3389\/fendo.2021.742089","article-title":"Recombinant human follicle stimulating hormone alfa dose adjustment in US clinical practice: an observational, retrospective analysis of a real-world electronic medical records database","volume":"12","author":"Mahony","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib41","first-page":"CD012693","article-title":"Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in\u00a0vitro fertilisation plus intracytoplasmic sperm injection (IVF\/ICSI)","volume":"2","author":"Lensen","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.bpobgyn.2022.102301_bib42","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.fertnstert.2016.10.033","article-title":"Individualized versus conventional ovarian stimulation for in\u00a0vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial","volume":"107","author":"Nyboe Andersen","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib43","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.rbmo.2014.11.013","article-title":"Randomized, controlled, open-label, non-inferiority study of the CONSORT algorithm for individualized dosing of follitropin alfa","volume":"30","author":"Olivennes","year":"2015","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib44","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.fertnstert.2020.03.029","article-title":"Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection","volume":"114","author":"Witz","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib45","author":"Batista","year":"2021"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib46","series-title":"Bemfola: summary of product characteristic London","year":"2019"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib47","series-title":"Ovaleap: summary of product charactersitics","year":"2019"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib48","series-title":"Gonal-f: summary of product characteristics","year":"2020"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib49","first-page":"CD008046","article-title":"Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology (Review)","volume":"50","author":"Youssef","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib50","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fendo.2017.00116","article-title":"GnRH agonist trigger and LH activity luteal phase support versus hCG trigger and conventional luteal phase support in fresh embryo transfer IVF\/ICSI cycles-A systematic PRISMA review and meta-analysis","volume":"8","author":"Haahr","year":"2017","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2022.102301_bib51","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.fertnstert.2004.03.055","article-title":"Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in\u00a0vitro fertilization","volume":"82","author":"Schmidt","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1477-7827-10-32","article-title":"Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment","volume":"10","author":"Fiedler","year":"2012","journal-title":"Reprod Biol Endocrinol : RBE (Rev Bras Entomol)"},{"issue":"6","key":"10.1016\/j.bpobgyn.2022.102301_bib53","first-page":"1009","article-title":"Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents: a report on women undergoing in\u00a0vitro fertilization and embryo transfer","volume":"81","author":"Sher","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib54","first-page":"CD002811","article-title":"Coasting (withholding gonadotrophins) for preventing ovarianhyperstimulation syndrome","volume":"15","author":"D'Angelo","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib55","first-page":"CD008605","article-title":"Dopamine agonists for preventing ovarian hyperstimulation syndrome","volume":"4","author":"Tang","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib56","article-title":"Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome","volume":"21","author":"Tso","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib57","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.bpobgyn.2022.102301_bib58","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/der251","article-title":"An OHSS-Free Clinic by segmentation of IVF treatment","volume":"26","author":"Devroey","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib59","doi-asserted-by":"crossref","first-page":"E151","DOI":"10.1016\/j.fertnstert.2011.06.057","article-title":"A\u00a0case of severe early-onset OHSS after GnRH-agonist triggering","volume":"98","author":"Kol","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib60","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/humupd\/dmy033","article-title":"Fresh versus elective frozen embryo transfer in IVF\/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes","volume":"25","author":"Roque","year":"2018","journal-title":"Hum Reprod Update"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.102301_bib61","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/humrep\/dey388","article-title":"Higher probability of live-birth in high, but not normal, responders after first frozen-embryo transfer in a freeze-only cycle strategy compared to fresh-embryo transfer: a meta-analysis","volume":"34","author":"Bosdou","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib62","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.rbmo.2020.11.008","article-title":"How frequent is severe ovarian hyperstimulation syndrome after GnRH agonist triggering in high-risk women? A systematic review and meta-analysis","volume":"42","author":"Ioannidou","year":"2021","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.102301_bib63","first-page":"9","article-title":"Fresh versus frozen embryo transfer after gonadotropin-releasing hormone agonist trigger in gonadotropin-releasing hormone antagonist cycles among high responder women: a randomized, multi-center study","volume":"16","author":"Aflatoonian","year":"2018","journal-title":"International journal of reproductive biomedicine"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib64","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1513873","article-title":"Fresh versus frozen embryos for infertility in the polycystic ovary syndrome","volume":"375","author":"Chen","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.bpobgyn.2022.102301_bib65","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.rbmo.2020.10.008","article-title":"Is there an optimal number of oocytes retrieved at which live birth rates or cumulative live birth rates per aspiration are maximized after ART? A systematic review","volume":"42","author":"Law","year":"2021","journal-title":"Reprod Biomed Online"},{"issue":"12","key":"10.1016\/j.bpobgyn.2022.102301_bib66","first-page":"2703","article-title":"Cumulative live birth rate: time for a consensus?","volume":"30","author":"Maheshwari","year":"2015","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.bpobgyn.2022.102301_bib67","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoac030","article-title":"Women's preferences concerning IVF treatment: a discrete choice experiment with particular focus on embryo transfer policy","volume":"2022","author":"Cornelisse","year":"2022","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib68","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1093\/humrep\/deab152","article-title":"Cumulative delivery rate per aspiration IVF\/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients","volume":"36","author":"Esteves","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib69","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.fertnstert.2018.04.039","article-title":"Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in\u00a0vitro fertilization\/intracytoplasmic sperm injection: a multicenter multinational analysis including 15,000 women","volume":"110","author":"Polyzos","year":"2018","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.bpobgyn.2022.102301_bib70","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.fertnstert.2016.10.037","article-title":"How many oocytes are optimal to achieve multiple live births with one stimulation cycle? The one-and-done approach","volume":"107","author":"Vaughan","year":"2017","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.bpobgyn.2022.102301_bib71","first-page":"370","article-title":"Conventional ovarian stimulation and single embryo transfer for IVF\/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?","volume":"31","author":"Drakopoulos","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib72","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1007\/s10815-019-01566-y","article-title":"Contribution of cryopreservation to the cumulative live birth rate: a large multicentric cycle-based data analysis from the Italian National Registry","volume":"36","author":"Scaravelli","year":"2019","journal-title":"J\u00a0Assist Reprod Genet"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib73","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/humupd\/dmr008","article-title":"GnRH agonist for triggering of final oocyte maturation: time for a change of practice?","volume":"17","author":"Humaidan","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib74","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1472-6483(10)60006-5","article-title":"Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study","volume":"18","author":"Humaidan","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib75","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/humrep\/det249","article-title":"GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients","volume":"28","author":"Humaidan","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib76","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/humrep\/det304","article-title":"Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study","volume":"28","author":"Iliodromiti","year":"2013","journal-title":"Hum Reprod"},{"issue":"12","key":"10.1016\/j.bpobgyn.2022.102301_bib77","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1093\/humrep\/deaa226","article-title":"The freeze-all strategy versus agonist triggering with low-dose hCG for luteal phase support in IVF\/ICSI for high responders: a randomized controlled trial","volume":"35","author":"Santos-Ribeiro","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib78","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.fertnstert.2015.01.034","article-title":"Luteal phase supplementation after gonadotropin-releasing hormone agonist trigger in fresh embryo transfer: the American versus European approaches","volume":"103","author":"Humaidan","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib79","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.rbmo.2015.12.007","article-title":"GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: a SWOT analysis","volume":"32","author":"Engmann","year":"2016","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib80","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.rbmo.2015.12.007","article-title":"GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: a SWOT analysis","volume":"32","author":"Engmann","year":"2016","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib81","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12958-021-00882-2","article-title":"A\u00a0comparative, observational study evaluating dosing characteristics and ovarian response using the recombinant human follicle-stimulating hormone pen injector with small-dose dial in assisted reproductive technologies treatment in Asia: IMPROVE study","volume":"20","author":"Choi","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib82","series-title":"Puregon: summary of product characteristics","year":"2021"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib83","series-title":"Elonva: summary of product charateristics","year":"2021"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib84","series-title":"Information REP","year":"2022"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib85","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.rbmo.2011.11.014","article-title":"Targeted gonadotrophin stimulation using the PIVET algorithm markedly reduces the risk of OHSS","volume":"24","author":"Yovich","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib86","first-page":"315","article-title":"A\u00a0redesigned follitropin alfa pen injector for infertility: results of a market research study","volume":"5","author":"Abbotts","year":"2011","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib87","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1080\/17425247.2017.1237940","article-title":"Dose accuracy of the redesigned follitropin alfa pen injector for infertility treatment","volume":"13","author":"Jeannerot","year":"2016","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib88","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1080\/17425247.2016.1203899","article-title":"Usability engineering study in the European Union of a redesigned follitropin alfa pen injector for infertility treatment","volume":"13","author":"Jeannerot","year":"2016","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib89","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/17425247.2018.1450386","article-title":"Nurse evaluation of the redesigned fertility pen injector: a questionnaire-based observational survey","volume":"15","author":"Schertz","year":"2018","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib90","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/17425247.2017.1289174","article-title":"Patient evaluation of the redesigned follitropin alfa pen injector","volume":"14","author":"Schertz","year":"2017","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib91","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1080\/17425247.2019.1651290","article-title":"An evaluation of the use and handling errors of currently available recombinant human follicle-stimulating hormone pen injectors by women with infertility and fertility nurses","volume":"16","author":"Longobardi","year":"2019","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib92","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.fertnstert.2014.01.019","article-title":"Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and \"freeze-all\" approach in GnRH antagonist protocol","volume":"101","author":"Fatemi","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib93","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1093\/humrep\/det124","article-title":"Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG","volume":"28","author":"Seyhan","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib94","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fendo.2019.00099","article-title":"A\u00a0novel predictive model to estimate the number of mature oocytes required for obtaining at least one euploid blastocyst for transfer in couples undergoing in\u00a0vitro fertilization\/intracytoplasmic sperm injection: the ART calculator","volume":"10","author":"Esteves","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib95","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2013.04.024","article-title":"Prediction of an excessive response in in\u00a0vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis","volume":"100","author":"Broer","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2022.102301_bib96","series-title":"Royal college of obstetricians and gynaecologists: The management of ovarian hyperstimulation syndrome","year":"2016"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693422001821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693422001821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:14:40Z","timestamp":1761498880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693422001821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":96,"alternative-id":["S1521693422001821"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2022.102301","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment algorithms for high responders: What we can learn from randomized controlled trials, real-world data and models","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2022.102301","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102301"}}